Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Imperial Oil
IMO
$64.9B
| $7.69M | 0.01% |
295,500
+141,000
| +91% | +$3.72M |
|
1552
M&T Bank
MTB
$36.8B
| $7.67M | 0.01% |
48,542
-167,000
| -77% | -$26.3M |
|
1553
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.78B
| $7.67M | 0.01% |
76,855
-9,845
| -11% | -$983K |
|
1554
American Vanguard Corp
AVD
$62.8M
| $7.66M | 0.01% |
488,100
-107,752
| -18% | -$1.58M |
|
1555
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.7B
| $7.66M | 0.01% |
+828,300
| New | +$10.7M |
|
1556
Allegion
ALLE
$14B
| $7.65M | 0.01% |
73,800
-26,100
| -26% | -$2.66M |
|
|
ACBI
1557
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $7.65M | 0.01% |
441,108
+129,113
| +41% | +$2.24M |
|
1558
Victory Capital Holdings
VCTR
$7.29B
| $7.65M | 0.01% |
497,247
-4,716
| -0.9% | -$80.7K |
|
|
TWNK
1559
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $7.63M | 0.01% |
545,500
+443,700
| +436% | +$6.29M |
|
1560
Nutrien
NTR
$32.5B
| $7.62M | 0.01% |
+152,910
| New | +$7.8M |
|
1561
iShares China Large-Cap ETF
FXI
$4.17B
| $7.62M | 0.01% |
+191,500
| New | +$7.77M |
|
1562
Bilibili
BILI
$7.27B
| $7.62M | 0.01% |
539,700
+45,400
| +9% | +$682K |
|
|
BELFB
1563
Bel Fuse Inc Class B
BELFB
$4.17B
| $7.62M | 0.01% |
506,823
-12,616
| -2% | -$175K |
|
1564
Teekay
TK
$1.09B
| $7.62M | 0.01% |
1,904,065
+284,865
| +18% | +$1.14M |
|
|
DHC
1565
Diversified Healthcare Trust
DHC
$2.02B
| $7.6M | 0.01% |
+821,206
| New | +$7.08M |
|
|
NTUS
1566
DELISTED
Natus Medical Inc
NTUS
| $7.6M | 0.01% |
238,600
+76,200
| +47% | +$2.22M |
|
|
TNAV
1567
DELISTED
Telenav Inc.
TNAV
| $7.59M | 0.01% |
1,587,369
+582,500
| +58% | +$4.9M |
|
1568
Compañía de Cervecerías Unidas
CCU
$2.17B
| $7.59M | 0.01% |
341,900
+68,300
| +25% | +$1.73M |
|
1569
Appian
APPN
$2.57B
| $7.57M | 0.01% |
159,400
+61,100
| +62% | +$2.86M |
|
1570
Sasol
SSL
$7.39B
| $7.56M | 0.01% |
444,366
+281,766
| +173% | +$5.74M |
|
1571
Freshpet
FRPT
$3.53B
| $7.53M | 0.01% |
151,300
-184,900
| -55% | -$8.45M |
|
1572
Insperity
NSP
$1.99B
| $7.53M | 0.01% |
76,346
-417,900
| -85% | -$45.4M |
|
1573
State Street Utilities Select Sector SPDR ETF
XLU
$23.1B
| $7.53M | 0.01% |
232,600
+45,200
| +24% | +$1.39M |
|
1574
C&F Financial
CFFI
$286M
| $7.53M | 0.01% |
142,900
-300
| -0.2% | -$15.3K |
|
1575
Dorian LPG
LPG
$2.01B
| $7.5M | 0.01% |
724,461
+462,061
| +176% | +$4.52M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.